Table 5. Effectiveness of montelukast compared to placebo in the atopic eczema group.
Changes after taking Montelukast (Mean±SD) |
Changes after taking Placebo drug (Mean±SD) |
P value | |
---|---|---|---|
SCORAD index | -5.4±8.6 | -7.7±10.2 | 0.51 |
Urine LTE4 (pg/mL) | 4.8±528.0 | 61.8±661.8 | 0.72 |
Urine EDN (ng/mL) | 160.5±1,068.6 | -6.9±963.3 | 0.20 |
SCORAD, SCORing Atopic Dermatitis; LTE4, leukotriene E4; EDN, eosinophil-derived neurotoxin.